As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...
Manufacturers are developing platform technologies for personalized CRISPR gene-editing therapies following the Baby KJ case.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results